Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report

Published:2020-03 Issue:3 Volume:31 Page:304-309
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Ota Shinichiro,Shimonaga Takashi,Yuki Shintaro,Kuraoka Kazuya,Ogawa Toshiya,Hirata Taizo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference27 articles.

1. Sarcoma classification: an update based on the 2013 world health organization classification of tumors of soft tissue and bone.;Doyle;Cancer,2014

2. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.;Ferrari;Cancer,2003

3. Rhabdomyosarcoma and extraosseous Ewing sarcoma.;Gurria;Children (Basel),2018

4. Childhood rhabdomyosarcoma.;Rodeberg;Semin Pediatr Surg,2006

5. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the Children’s Oncology Group.;Spunt;Clin Cancer Res,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering Cardiac Sarcomas: Etiology, Diagnosis, and Therapeutic Frontiers;Cardiovascular Innovations and Applications;2024

2. Cardiac Tumors: Review;BRAZ J CARDIOV SURG;2024

3. An Unusual Presentation of a Rare Case of Rhabdomyosarcoma of the Left Atrium as Severe Rheumatic Mitral Stenosis with Atrial Fibrillation, Fast Ventricular Rate, and Left Atrial Failure;Research in Cardiovascular Medicine;2023

4. Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism;Molecular Carcinogenesis;2022-04-26

5. Multiple drugs;Reactions Weekly;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3